Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis
- PMID: 26764028
- DOI: 10.1212/WNL.0000000000002350
Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis
Abstract
Objective: To evaluate the diagnostic accuracy of clinical diagnosis of Parkinson disease (PD) reported in the last 25 years by a systematic review and meta-analysis.
Methods: We searched for articles published between 1988 and August 2014. Studies were included if reporting diagnostic parameters regarding clinical diagnosis of PD or crude data. The selected studies were subclassified based on different study setting, type of test diagnosis, and gold standard. Bayesian meta-analyses of available data were performed.
Results: We selected 20 studies, including 11 using pathologic examination as gold standard. Considering only these 11 studies, the pooled diagnostic accuracy was 80.6% (95% credible interval [CrI] 75.2%-85.3%). Accuracy was 73.8% (95% CrI 67.8%-79.6%) for clinical diagnosis performed mainly by nonexperts. Accuracy of clinical diagnosis performed by movement disorders experts rose from 79.6% (95% CrI 46%-95.1%) of initial assessment to 83.9% (95% CrI 69.7%-92.6%) of refined diagnosis after follow-up. Using UK Parkinson's Disease Society Brain Bank Research Center criteria, the pooled diagnostic accuracy was 82.7% (95% CrI 62.6%-93%).
Conclusion: The overall validity of clinical diagnosis of PD is not satisfying. The accuracy did not significantly improve in the last 25 years, particularly in the early stages of disease, where response to dopaminergic treatment is less defined and hallmarks of alternative diagnoses such as atypical parkinsonism may not have emerged. Misclassification rate should be considered to calculate the sample size both in observational studies and randomized controlled trials. Imaging and biomarkers are urgently needed to improve the accuracy of clinical diagnosis in vivo.
© 2016 American Academy of Neurology.
Similar articles
-
Clinical Diagnostic Accuracy of Parkinson's Disease: Where Do We Stand?Mov Disord. 2023 Apr;38(4):558-566. doi: 10.1002/mds.29317. Epub 2023 Jan 5. Mov Disord. 2023. PMID: 36602274
-
Validation of the MDS clinical diagnostic criteria for Parkinson's disease.Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25. Mov Disord. 2018. PMID: 30145797
-
Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.BMC Neurol. 2018 May 16;18(1):69. doi: 10.1186/s12883-018-1072-x. BMC Neurol. 2018. PMID: 29764386 Free PMC article.
-
Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.Parkinsonism Relat Disord. 2017 Sep;42:1-11. doi: 10.1016/j.parkreldis.2017.06.006. Epub 2017 Jun 15. Parkinsonism Relat Disord. 2017. PMID: 28647434 Review.
-
Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's disease: A Systematic Review and Meta-analysis.Sci Rep. 2016 Feb 16;6:20863. doi: 10.1038/srep20863. Sci Rep. 2016. PMID: 26878893 Free PMC article. Review.
Cited by
-
The rise of Parkinson's disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and "eat, move, sleep" lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand.Front Neurol. 2024 May 13;15:1386608. doi: 10.3389/fneur.2024.1386608. eCollection 2024. Front Neurol. 2024. PMID: 38803644 Free PMC article.
-
Integrated Bioinformatics Analysis for Revealing CBL is a Potential Diagnosing Biomarker and Related Immune Infiltration in Parkinson's Disease.Int J Gen Med. 2024 May 22;17:2371-2386. doi: 10.2147/IJGM.S456942. eCollection 2024. Int J Gen Med. 2024. PMID: 38799203 Free PMC article.
-
Machine Learning Models for Parkinson Disease: Systematic Review.JMIR Med Inform. 2024 May 17;12:e50117. doi: 10.2196/50117. JMIR Med Inform. 2024. PMID: 38771237 Free PMC article. Review.
-
Systematic genome-wide Mendelian randomization reveals the causal links between miRNAs and Parkinson's disease.Front Neurosci. 2024 May 3;18:1385675. doi: 10.3389/fnins.2024.1385675. eCollection 2024. Front Neurosci. 2024. PMID: 38765669 Free PMC article.
-
Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review.PLoS One. 2024 May 16;19(5):e0303644. doi: 10.1371/journal.pone.0303644. eCollection 2024. PLoS One. 2024. PMID: 38753740 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical